tiprankstipranks
Newron Pharmaceuticals SpA (NWPHF)
:NWPHF
US Market

Newron Pharmaceuticals SpA (NWPHF) Financial Statements

Compare
9 Followers

Newron Pharmaceuticals SpA Financial Overview

Newron Pharmaceuticals SpA's market cap is currently $229.38M. The company's EPS TTM is $-1.118; its P/E ratio is ―; Newron Pharmaceuticals SpA is scheduled to report earnings on March 18, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Dec 21Dec 20Dec 19Dec 18
Income Statement
Total Revenue
Gross Profit--$ 4.96M$ 5.61M$ 2.65M
Operating Income$ -13.30M$ -12.36M$ -18.07M$ -20.90M$ -14.98M
EBITDA$ -13.32M$ -11.76M$ -17.16M$ -19.29M$ -14.44M
Net Income$ -17.49M$ -14.90M$ -21.00M$ -20.21M$ -15.04M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 37.20M$ 50.49M$ 51.20M$ 60.29M$ 60.00M
Total Debt$ 45.66M$ 43.08M$ 26.34M$ 16.89M$ 276.00K
Net Debt$ 22.89M$ 8.49M$ -4.91M$ -22.28M$ -43.58M
Total Liabilities$ 51.23M$ 47.38M$ 33.95M$ 23.49M$ 5.16M
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -11.11M$ -11.46M$ -15.62M$ -22.03M$ -15.99M
Operating Cash Flow$ -11.09M$ -11.45M$ -15.59M$ -21.98M$ -15.95M
Investing Cash Flow
Financing Cash Flow
Currency in USD

Newron Pharmaceuticals SpA Earnings and Revenue History

Newron Pharmaceuticals SpA Debt to Assets

Newron Pharmaceuticals SpA Cash Flow

Newron Pharmaceuticals SpA Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis